Cargando…

Case report: Patiromer-induced hypercalcemia

Patiromer is a novel potassium-binding compound which has recently received FDA approval. This ion exchange resin releases calcium when it binds potassium. We describe the development of hypercalcemia after initiation of patiromer. The calcium levels fell when the drug was stopped but recurred when...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiederkehr, Michael R., Mehta, Ankit N., Emmett, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691394/
https://www.ncbi.nlm.nih.gov/pubmed/31410346
http://dx.doi.org/10.5414/CNCS109782